MedTrace Logo

Aerobic vs Core Stability Exercise Training Program in Women With Endometriosis

NCT05834283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-04-28

No results posted yet for this study

Summary

To compare the effects of aerobic and core stability exercise training program on pain, sleep and quality of life in women with endometriosis.

Conditions

  • Endometriosis

Interventions

OTHER

aerobic exercises

This group will be received aerobic exercises 3 sessions per week for 8 weeks. Warm up phase: in which each participant will walk at 80 m/min at 0.0% grade for 5 mint. Active phase: treadmill speed will be increased to 147 m/min and grade will be increased gradually untill reached 25% grade for 20 mint. Cool down phase: in which the treadmil speed and grade will be decreased to 2.0miles/h and 0.0% grade during a cool down period consisted of 5 mint.

OTHER

core stability exercises

This group will be received core stability exercises 3 sessions per week for 8 weeks. All participants in both groups will be evaluated before and after the treatment programs. Lie on your back and place your feet on a wall so that your knees and hips are bent at 90 degrees angles. Tighten your abdominal muscles. Raise your head and shoulders off the floor. Return to the start position and repeat.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Hafiza Neelam, PPDPT · Riphah International University, Senior lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
24 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-01-08
Completion
2023-03-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05834283 on ClinicalTrials.gov